Point of Care Microfluidic Aggrogometer

Technology #ua17-170

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Alberto Redaelli
Professor of BioMechanics, Dipartimento di Elettronica
Marvin Slepian
Professor, Medicine
Managed By
Rakhi Gibbons
Asst. Director, Life Sciences (520) 626-6695

Title: Point of Care Microfluidic Aggrogometer


Invention: The invention is a device to assess platelet aggregation for diagnosis of thrombotic diseases and continual monitoring with anti-platelet therapy.


Background: Heart disease is the leading cause of death in the United States and, with over 50% of those deaths due to clot formation from myocardial ischemia and infarction. Anti-platelet therapies commonly used are aspirin, clopidogrel, and prasugrel. Monitoring anti-platelet therapy is currently not done on a routine basis due to a lack of a standardized definition of ineffectual anti-platelet therapy. With that said, there is a need for a widely-accepted point-of-care platelet function test that is reliable, accurate, and easy to use in clinics.



  • Platelet function testing
  • Pharmaceutical industry
  • Diagnostics



  • Measures onset and progression
  • Measures degree of severity
  • Assesses response to anti-platelet therapy


Licensing Manager:

Rakhi Gibbons


(520) 626-6695